Uneyama Mizuho, Toyoda Takeshi, Doi Yuko, Matsushita Kohei, Akane Hirotoshi, Morikawa Tomomi, Ogawa Kumiko
Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.
DIMS Institute of Medical Science, Inc., 64 Goura, Nishiazai, Azai-cho, Ichinomiya, Aichi 491-0113, Japan.
J Toxicol Pathol. 2024 Oct;37(4):151-161. doi: 10.1293/tox.2024-0012. Epub 2024 Jul 2.
Linalool oxide is frequently used as a flavoring agent, however, data on its toxicity is limited. In this study, we performed a 13-week subchronic toxicity study of linalool oxide (furanoid) in male and female Crl:CD(SD) rats. Doses of 0, 80, 250, and 800 mg/kg body weight (bw) per day were orally administered by gavage, using corn oil as the vehicle. Abnormal gait in both sexes and decreased locomotor activity in males were observed in the 800 mg/kg group. Reduced body weight gain was noted in both sexes at 800 mg/kg and at 250 mg/kg in males. In the 800 mg/kg group, serum biochemistry showed increased γ-glutamyl transpeptidase and decreased glucose in both sexes, increased total protein in males, and increased total cholesterol and phospholipids in females, suggesting that linalool oxide may have adverse effects on the liver. Increased relative and/or absolute liver weights, centrilobular hepatocellular hypertrophy in both sexes, and periportal microvesicular fatty changes in females were observed in the 800 mg/kg group. Increased relative liver weights and decreased serum glucose levels were observed in the 250 mg/kg male and female groups, respectively. Increased serum magnesium levels and relative kidney weights were observed in both sexes in the 800 mg/kg group, suggesting possible adverse effects of linalool oxide. Although histopathology showed accumulation of hyaline droplets in the male kidneys, immunohistochemistry revealed α-globulin nephropathy, which was not considered toxicologically significant. These results indicate that the no-observed-adverse-effect level of linalool oxide was 80 mg/kg bw/day for both sexes.
氧化芳樟醇常被用作调味剂,然而,关于其毒性的数据有限。在本研究中,我们对雄性和雌性Crl:CD(SD)大鼠进行了为期13周的氧化芳樟醇(呋喃型)亚慢性毒性研究。每天通过灌胃口服给予0、80、250和800mg/kg体重(bw)的剂量,使用玉米油作为赋形剂。在800mg/kg组中观察到两性均出现异常步态,雄性的运动活性降低。在800mg/kg组的两性以及250mg/kg组的雄性中均注意到体重增加减少。在800mg/kg组中,血清生化指标显示两性的γ-谷氨酰转肽酶升高、葡萄糖降低,雄性的总蛋白升高,雌性的总胆固醇和磷脂升高,这表明氧化芳樟醇可能对肝脏有不良影响。在800mg/kg组中观察到两性的相对和/或绝对肝脏重量增加、小叶中央肝细胞肥大,雌性出现门静脉周围微泡性脂肪变化。在250mg/kg的雄性和雌性组中分别观察到相对肝脏重量增加和血清葡萄糖水平降低。在800mg/kg组的两性中均观察到血清镁水平和相对肾脏重量增加,这表明氧化芳樟醇可能有不良影响。尽管组织病理学显示雄性肾脏中有透明滴状物质积聚,但免疫组织化学显示为α球蛋白肾病,在毒理学上不认为具有显著性。这些结果表明,氧化芳樟醇对两性的未观察到不良反应水平均为80mg/kg bw/天。